Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Archives for September 2019

Mets Activate Jed Lowrie

By | at

The Mets are set to welcome one of their offseason additions, as infielder Jed Lowrie has been activated from the injured list, according to Tim Healey of Newsday. In addition, Dominic Smith has been transferred to the 60-day injured list and right-hander Drew Gagnon has been recalled from Triple-A.

Lowrie, one of the Mets’ significant signings of the offseason, has yet to play a game in his new uniform due to a series of left leg injuries affecting the knee, hamstring, and calf. Lowrie, 35, inked a 2-year, $20MM contract with the Mets but began the season on the injured list with a left knee capsule strain that emerged in Spring Training. However, a hamstring strain in May delayed the timetable for his recovery, and it seems that rehab subsequently snowballed into a complicated mess of recovery and re-injury.

With Robinson Cano and Todd Frazier installed at second and third base, respectively, it’s unclear just how much playing time Lowrie will receive. In that regard, not much has changed since Lowrie was signed, when the fit appeared questionable, given the team’s invested in Cano and the presence of promising youngster Jeff McNeil. At the very least, he’ll be able to offer some return on the first year of the Mets’ investment. He’s coming off a pair of productive seasons in Oakland, posting a cumulative OPS of .804, including a career-best 23 home runs last season. While he likely isn’t at full health yet, the Mets will hope for signs that Lowrie isn’t far off those numbers—not only for this season, but with an eye on 2020 as well.

Meanwhile, Smith may very well have played his last game this season; now on the 60-day IL, the earliest he could return would come in the final week of the regular season. If indeed his season is over, he’ll close the book on a breakthrough age-24 season in which he has slashed .278/.352/.506 in a part-time role. However, Anthony DiComo of MLB.com reports that there’s a chance he could be cleared to make another appearance or two, as he’ll be reevaluated in his recovery from a stress fracture in his left foot.

Michael Pineda Receives 60-Game PED Suspension

By | at

Minnesota Twins right-handed pitcher Michael Pineda has been suspended for 60 games for violating MLB’s drug policy, reports Jon Heyman of MLB Network. He’ll miss the remainder of the season and is not eligible for postseason play.

Per Do-Hyoung Park of MLB.com, the 30-year-old Pineda tested positive for hydrochlorothiazide, a diuretic on MLB’s list of banned substances. Though that diuretic itself is not a performance-enhancing drug, it is often used in conjunction with PEDs for a masking effect. ESPN’s Jeff Passan adds that Pineda was initially tagged with an 80-game ban—standard procedure for first-time offenders—but an appeal brought that number down to 60 after providing evidence that the substance in Pineda’s system was not used as a masking agent for PEDs.

After undergoing Tommy John surgery in July 2017, Pineda caught on with the Twins on a two-year deal worth $10MM. Forced to sit out the entire 2018 season, Minnesota knew that it was only paying for one healthy season of Pineda, and his rebound has certainly been a respectable one. Though by no means a top-tier starter, he’s added depth to a Twins rotation that desperately needed it. He’s slotted in as the Twins third-best starter, posting a 4.01 ERA while racking up 146 innings for a playoff team. This year, he’s struck out 140 batters compared to just 28 walks, good for a clean 5.00 K:BB ratio.

His numbers have been even better over the last three-plus months, though, as it presumably took some time for the ex-Yankee to regain his feel for pitching after a lost season. Since the calendar turned to June, Pineda is sporting a sterling 3.10 ERA while striking out more than a batter per inning. During that stretch, he has indeed been the most reliable Minnesota starter.

However, that production will now be absent from any October games, with the suspension rendering Pineda ineligible for postseason play. That represents a considerable blow for the Twins, whose rotation has greatly benefited from the solid second-half presence of Pineda. Jose Berrios and Jake Odorizzi are an All-Star pairing, and Pineda would have given the Twins the makings of a respectable playoff rotation.

Instead, Kyle Gibson and Martin Perez will be relied upon to comprise half of that unit. Though Gibson and Perez have been valuable to the Twins in their own right, both have graded out a notch below Pineda, a disparity that could be magnified in a short series where pitching is often king. Gibson, currently on the injured list, is the more reliable of that duo: his 4.04 FIP compares favorably to Pineda’s and he owns a better track record of solid production. Perez, meanwhile, has made considerable adjustments to increase his staying power, though he still struggles with command and inconsistency. He is sporting just a 1.98 K:BB ratio to go with a 4.75 ERA.

Pineda issued a statement regarding his suspension through the MLB Players Association.

Giants Claim Wandy Peralta

By | at

The Giants have claimed left-handed pitcher Wandy Peralta off waivers from the Reds, according to C. Trent Rosecrans of The Athletic. He’ll report to his new club on Monday, tweets Andrew Baggarly of The Athletic, adding that the Giants have placed infielder Zach Green on the 60-day injured list thanks to a hip impingement.

Peralta has thrown 34 innings for the Reds this year, striking out 27 batters and walking 15 en route to a 6.09 ERA. He hasn’t been able to duplicate the success he generated in 2017, but he’ll have a chance for a change of scenery as he joins the stable of Giants relievers for a September tryout.

MLB, Players Association Discuss Prospect Of Mandated Opioid Testing

By | at

Major League Baseball and the Players Association have no shortage of topics to talk about these days, but a new issue has forced its way onto the agenda: opioid testing. The autopsy results after the tragic passing of Tyler Skaggs turned this national conversation into a touch point for MLB, and the two sides are discussing the possibilities of including random screenings for opioids into the official drug testing program, per Bill Shaikin of the Los Angeles Times.

Opioids do appear on the banned-substance list – a fine first step – but major league players aren’t subject to testing without reasonable cause. Tony Clark, the executive director of the Players Association, released a statement last Friday in which he said: “For several reasons, including the tragic loss of a member of our fraternity and other developments happening in the country as a whole, it is appropriate and important to reexamine all of our drug protocols relating to education, treatment and prevention.”

As drug testing has been an area of relative common ground in recent years, an accord here could inject a note of harmony to a negotiation largely fraught with skepticism.  Even so, don’t expect anything contractual in the near-term. The opioid crisis is but one issue among many being discussed in the lead up to CBA negotiations in 2021. MLB and the Players Association are meeting about once a month for these “early negotiations,” per The Athletic’s Evan Drellich. While these sessions could not be more foundational to the overall discussions, the goal of diplomacy at this stage is more to about gauging temperature than putting pen to paper.

Both sides cite player welfare as a primary objective of these preliminary talks, though at present, there’s little reason to suspect pervasive use of opioids throughout the game. What information they do have comes from mandated testing for minor leaguers, who lack union protection and therefore are subject to testing and discipline by the commissioner’s office. More than 78,000 tests have been conducted for minor league players, resulting in just 12 suspensions, per ESPN.com’s Jeff Passan.

Still, fentanyl is the leading cause of overdose deaths in the U.S., and the Skaggs autopsy provided an opportunity to be proactive. The rate and severity of injury puts players at risk for exposure through short-term surgical use, and most players certainly have the financial means to foster ongoing abuse should it become an issue. There is likely to be stronger solution in the new CBA, as leaving the safety of players to the discretion of team doctors is hardly the most comprehensive approach, not to mention the burden of responsibilities it places on the doctors themselves.

White Sox Promote Mike Shirley To Director Of Amateur Scouting

By | at

The Chicago White Sox promoted Mike Shirley to be their new Director of Amateur Scouting, per Tom Musick of the Chicago Sun Times. The move continues a bit of organizational reshuffling, as Shirley assumes the post vacated by Nick Hostetler, who himself took a new position as special assistant to GM Rich Hahn.

Shirley becomes the point man for June’s annual draft. It’s a tough assignment in some ways, as expectations will be high after the tremendous job the White Sox have done in recent years in building the #3 ranked farm system, per Baseball America.  Optics should be good for a couple of years while these recent picks graduate to the majors, guys like Nick Madrigal, Zack Collins, and Andrew Vaughn, high draft picks who are either in the majors now or on their way.

In an article from The Athletic’s James Fegan, Chicago’s new Director of Amateur Scouting spoke about their prospects for the upcoming 2020 draft.“There are a lot of good players out there,” Shirley said. “The game has changed. The younger players have a lot more impact today for a reason. The kids are more advanced at younger ages. We know that and I think that’s an exciting part of what baseball is becoming.”

That jives with the direction the franchise has taken in recent drafts, as they’ve begun to take more chances on high school players. Shirley will be tasked with maintaining a high degree of success, but he’s likely running out of ultra-high draft choices with which to work. With a record of 62-79, the White Sox are in line for a late top-10 pick in next June’s draft, but if all goes according to plan, this could be the last time picking in the top-10 for quite some time.

AL Injury Notes: Cruz, Gurriel, Springer

By | at

The Twins fell 6-2 in 11 innings to their chaser in the AL Central last night, yet they remain 5 1/2 games ahead of the Indians for the division crown. Minnesota is just 6-8 head-to-head against their eastern rival with five matchups remaining, all in the next ten days. More troublesome to the Twins, they may be without Nelson Cruz for at least these next couple showdowns. Cruz exited the ballgame in the tenth inning with wrist soreness, but he’s being listed as day-to-day, per MLB.com’s Do-Hyoung Park (via Twitter). Cruz carries an MVP-caliber bat when he’s healthy, arguably the best DH in the game with a .305/.385/.631 mark that pairs nicely with his traditional counting stats of 35 home runs and 92 RBIs. The wrist has been an issue for Cruz, however, as it’s already landed him on the IL twice. He was diagnosed with a ruptured ECU tendon back in March, but manager Rocco Baldelli insists the injury is nothing significant, tweets The Athletic’s Dan Hayes. Even minor injuries can have significant impact this time of year, of course, so let’s check in on a couple of injury scares for Minnesota’s potential dance partner in the upcoming ALDS.

  • Yuli Gurriel’s thunderous second half in Houston should return after just a brief interlude. The Astros first baseman left yesterday’s game with left hamstring discomfort, but he is considered day-to-day, per Mark Berman of Fox Houston. After authoring marks of .277/.314/.482 in the first half that fell just far enough below his career averages to spark fears of age-based decline for the 35-year-old, Yuli came out with a blistering second half: .351/.409/.660, pulling his overall productivity mark up to 135 wRC+, the 23rd highest mark in the majors. Gurriel’s leveling up paired with the arrival of Yordan Alvarez has made an already-strong Astros lineup certifiable.
  • In a separate tweet, Berman provides video of George Springer taking batting practice and having himself a time. This should be a welcome sight for the Houston faithful, who saw Springer suffer a mild concussion while colliding into the wall Tuesday night. It’s been a career year for Springer in this, his age-28 season, as he’s put up his most complete season to date with a line of .297/.389/.573. His 155 wRC+ pegs him as the 7th most-productive hitter in the majors this season, joining four of his Houston brethren in the top-25 among qualified hitters (Alvarez doesn’t yet qualify). From the looks of it, Springer should return to the Houston lineup shortly.

Latest On Corey Kluber

By | at

The Indians don’t seem to have much hope of getting veteran starter Corey Kluber back at any point in the 2019 season. As Ryan Lewis of the Beacon Journal recently reported, Kluber is still limited to doing aquatic exercises as he works to recover from an oblique injury.

That status hasn’t changed in the past few days, leading MLB.com’s Jordan Bastian to tweet that it’d be a surprise to see Kluber back in the regular season. Perhaps a postseason return can’t be ruled out entirely — remember Kyle Schwarber? — but it feels quite unlikely.

Trouble is, there just isn’t much time for Kluber to rebuild his arm strength even if he can get past the oblique issue. As skipper Terry Francona put it, “He’s got a ways to go.” Given that Kluber was already working back from a forearm fracture when he suffered the new injury, it’d be difficult to justify an aggressive build-up.

If indeed Kluber is done pitching for the year, it would mean the Indians won’t have a chance to glean further information before deciding on his club option. On the one hand, given Kluber’s still-recent history of dominance, it’s hard to imagine the team passing on the $13.5MM price tag in favor of $2MM in total buyouts. That’s particularly true with another option year still to come for 2021. On the other, the 33-year-old struggled even before he went down and will now be working back from a completely lost campaign. And the cost is far from insignificant to the budget-watching Cleveland organization.

Cubs Injury Updates: Baez, Darvish, Kimbrel

By | at

Cubs skipper Joe Maddon provided updates on an important trio of players today, with MLB.com’s Jordan Bastian among those covering the news. (Links to his Twitter account unless otherwise noted.)

  • Star infielder Javier Baez is going to undergo an MRI on his thumb tomorrow. There’s still no cause for alarm, but it’s certainly suboptimal to hear that he’s not recovering promptly after getting three games off. Initial x-rays came back negative, but the club is obviously interested in making sure there isn’t some other injury lurking in the digit. Deep as the Cubbies are in position players, Baez — who owns a .281/.316/.532 slash line with 29 home runs on the year — is all but irreplaceable. Baez certainly won’t be in the lineup until Sunday, at the earliest. The organization’s hope is that it won’t be long thereafter before he’s ready to return. Obviously, a significant injury would be devastating at this time of year.
  • Issues in or near the elbow are always a red flag for a pitcher, so it was at least somewhat worrisome to learn that righty Yu Darvish has experienced forearm tightness of late. But it seem he isn’t terribly concerned about it, having already managed things since early July — and thrived over that same span. The veteran says he won’t need to miss any further action after being skipped in his last scheduled start. He’ll pitch tomorrow. Maddon said Darvish looked great in his latest pen session and is “ready to roll,” as Mark Gonzales of the Chicago Tribune tweets.
  • Speaking of ailments in the elbow region, the Cubs were holding their breath when closer Craig Kimbrel went in for an MRI. He says that the results were quite promising and that he hopes to be ready to return when first eligible on Thursday. That said, the veteran hurler hasn’t yet resumed throwing after spending some time on ice to let his inflammation subside. As he acknowledged, the precise course of action will depend upon how it goes once he does get back on the bump.

Rich Hill To Start For Dodgers On Thursday

By | at

Dodgers southpaw Rich Hill laid out his plan for returning from a flexor tendon strain to reporters including Mike DiGiovanna of the Los Angeles Times (Twitter link). He’ll start on Thursday and plan to make four total regular-season outings in preparation for the postseason.

If the plan sounds somewhat optimistic, that’s probably somewhat by design. Hill says that he’s going to prepare as if he can fully ramp up down the stretch, without any rehab assignment. If adjustments are needed, they can be considered at the time.

Skipper Dave Roberts confirmed the general plan. He noted that Hill is likely only to throw two innings or thirty pitches in his preliminary outing, as Dodger Talk’s David Vassegh tweets. The ageless southpaw has been sidelined since late June, so he’s obviously in need of a gradual progression in terms of game action.

All things considered, this is excellent news for the powerhouse Dodgers. Hill was throwing brilliantly before he was injured. He could well make for a major addition to the postseason roster, even if he’s ultimately limited in how deep he can work.

This is also a notable development for the coming offseason market. Hill intends to keep playing and hopes to remain with the Dodgers, Andy McCullough of The Athletic reports as part of an excellent profile of the unique left-hander (subscription link). Hill’s health status will surely play a role in the way offseason talks unfold.

This news comes as the team deals with newfound struggles from fellow southpaw Hyun-Jin Ryu. The Dodgers will skip his next scheduled start, as DiGiovanna further tweets, in a bid to get the veteran some rest. On the positive side, it doesn’t seem as if there’s any health issue of note to worry about.

Mike Moustakas Struggling To Recover From Wrist Injury

By | at

Veteran Brewers infielder Mike Moustakas is struggling to make his way back from a recent injury in the vicinity of his left wrist, as MLB.com’s Adam McCalvy reports on Twitter. The club is “not making progress” in getting Moustakas back to full health, says skipper Craig Counsell.

It’s a bit of a surprise to see Moustakas still dealing with what Counsell calls “significant pain.” At the time of the injury, indications were that he had avoided a notable malady. While Moustakas was able to appear in two contests in the interim, he has sat out six games completely and evidently still isn’t making progress despite the wrist.

There’s little doubt that the club would like to get Moustakas back in action. He is a key part of the Brewers roster and there’s still an outside chance of the club staging a dash back into the Wild Card picture. At the same time, there’s little reason to force the issue if he won’t be at full speed. Meanwhile, Moustakas is again preparing to enter the free-agent market. That comes with its own pressures — both to get back on the field and to avoid injury.

Surely, all interested parties would like to simply get to the bottom of the matter and gain some clarity. At this point, though, the next steps aren’t clear. Regardless of how things shake out on the injury front, Moustakas has turned in impressive work this season. Through 520 plate appearances, he’s slashing .260/.331/.522 with 31 long balls. He

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top